Medical equipment maker Revvity on Monday joined larger peers in warning about the impact of tariffs imposed by the U.S.

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Businesses across multiple industries, including some of the world's largest conglomerates, are feeling the pinch of ...

Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors ...

Major companies are lowering or scrapping their earnings forecasts amid uncertainty from tariffs.

Scotiabank lowered the firm’s price target on Thermo Fisher (TMO) to $605 from $650 and keeps a Sector Perform rating on the shares. While it ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

Trump tariffs reshaping business strategies, roiling markets Pepsi, P&G, American Airlines and Thermo Fisher latest to cut ...

Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...